[HTML][HTML] Engineering neoantigen vaccines to improve cancer personalized immunotherapy

Z Liu, J Lv, Q Dang, L Liu, S Weng, L Wang… - … journal of biological …, 2022 - ncbi.nlm.nih.gov
Immunotherapy treatments harnessing the immune system herald a new era of personalized
medicine, offering considerable benefits for cancer patients. Over the past years, tumor …

Advances in the development of personalized neoantigen-based therapeutic cancer vaccines

E Blass, PA Ott - Nature reviews Clinical oncology, 2021 - nature.com
Within the past decade, the field of immunotherapy has revolutionized the treatment of many
cancers with the development and regulatory approval of various immune-checkpoint …

Challenges in developing personalized neoantigen cancer vaccines

PD Katsikis, KJ Ishii, C Schliehe - Nature Reviews Immunology, 2024 - nature.com
The recent success of cancer immunotherapies has highlighted the benefit of harnessing the
immune system for cancer treatment. Vaccines have a long history of promoting immunity to …

Development of neoantigens: from identification in cancer cells to application in cancer vaccines

N Ebrahimi, M Akbari, M Ghanaatian… - Expert Review of …, 2022 - Taylor & Francis
Introduction The discovery of neoantigens as mutated proteins specifically expressed in
tumor cells but not in normal cells has led to improved cancer vaccines. Targeting …

Recent development and clinical application of cancer vaccine: targeting neoantigens

RY Pan, WH Chung, MT Chu, SJ Chen… - Journal of …, 2018 - Wiley Online Library
Recently, increasing data show that immunotherapy could be a powerful weapon against
cancers. Comparing to the traditional surgery, chemotherapy or radiotherapy …

Neoantigen cancer vaccines: generation, optimization, and therapeutic targeting strategies

CR Reynolds, S Tran, M Jain, A Narendran - Vaccines, 2022 - mdpi.com
Alternatives to conventional cancer treatments are highly sought after for high-risk
malignancies that have a poor response to established treatment modalities. With research …

Designing neoantigen cancer vaccines, trials, and outcomes

N Biswas, S Chakrabarti, V Padul, LD Jones… - Frontiers in …, 2023 - frontiersin.org
Neoantigen vaccines are based on epitopes of antigenic parts of mutant proteins expressed
in cancer cells. These highly immunogenic antigens may trigger the immune system to …

Therapeutic vaccines targeting neoantigens to induce T-cell immunity against cancers

SC Pao, MT Chu, SI Hung - Pharmaceutics, 2022 - mdpi.com
Cancer immunotherapy has achieved multiple clinical benefits and has become an
indispensable component of cancer treatment. Targeting tumor-specific antigens, also …

Current trends in neoantigen-based cancer vaccines

SY Ho, CM Chang, HN Liao, WH Chou, CL Guo… - Pharmaceuticals, 2023 - mdpi.com
Cancer immunotherapies are treatments that use drugs or cells to activate patients' own
immune systems against cancer cells. Among them, cancer vaccines have recently been …

Identification of neoantigens for individualized therapeutic cancer vaccines

F Lang, B Schrörs, M Löwer, Ö Türeci… - Nature reviews Drug …, 2022 - nature.com
Somatic mutations in cancer cells can generate tumour-specific neoepitopes, which are
recognized by autologous T cells in the host. As neoepitopes are not subject to central …